SGLT-2抑制剂和芬烯酮治疗非糖尿病性CKD:迈向(近期)未来?

{"title":"SGLT-2抑制剂和芬烯酮治疗非糖尿病性CKD:迈向(近期)未来?","authors":"Marieta P Theodorakopoulou, Pantelis A Sarafidis","doi":"10.1093/ckj/sfad272","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":18987,"journal":{"name":"NDT Plus","volume":"7 12 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"SGLT-2 inhibitors and finerenone in non-diabetic CKD: a step into the (near) future?\",\"authors\":\"Marieta P Theodorakopoulou, Pantelis A Sarafidis\",\"doi\":\"10.1093/ckj/sfad272\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":18987,\"journal\":{\"name\":\"NDT Plus\",\"volume\":\"7 12 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-10-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"NDT Plus\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/ckj/sfad272\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"NDT Plus","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/ckj/sfad272","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}